Twist Bioscience Corporation (TWST)

USD 44.61

(-7.83%)

Total Debt Summary of Twist Bioscience Corporation

  • Twist Bioscience Corporation's latest annual total debt in 2023 was 94.06 Million USD , down -0.89% from previous year.
  • Twist Bioscience Corporation's latest quarterly total debt in 2024 Q3 was 87.18 Million USD , down -2.51% from previous quarter.
  • Twist Bioscience Corporation reported annual total debt of 94.91 Million USD in 2022, up 50.84% from previous year.
  • Twist Bioscience Corporation reported annual total debt of 62.92 Million USD in 2021, up 74.87% from previous year.
  • Twist Bioscience Corporation reported quarterly total debt of 89.42 Million USD for 2024 Q2, down -2.67% from previous quarter.
  • Twist Bioscience Corporation reported quarterly total debt of 91.87 Million USD for 2024 Q1, down -2.33% from previous quarter.

Annual Total Debt Chart of Twist Bioscience Corporation (2023 - 2016)

Historical Annual Total Debt of Twist Bioscience Corporation (2023 - 2016)

Year Total Debt Total Debt Growth
2023 94.06 Million USD -0.89%
2022 94.91 Million USD 50.84%
2021 62.92 Million USD 74.87%
2020 35.98 Million USD 365.3%
2019 7.73 Million USD -20.43%
2018 9.71 Million USD 6.16%
2017 9.15 Million USD -18.13%
2016 11.18 Million USD 0.0%

Peer Total Debt Comparison of Twist Bioscience Corporation

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD -6.961%
Prenetics Global Limited 2.36 Million USD -3870.181%
Star Equity Holdings, Inc. 3.6 Million USD -2506.511%
CareDx, Inc 34.22 Million USD -174.887%
Exact Sciences Corporation 2.55 Billion USD 96.318%
Exagen Inc. 23.72 Million USD -296.564%
Inotiv, Inc. 417.64 Million USD 77.476%
Guardant Health, Inc. 1.35 Billion USD 93.051%
Biodesix, Inc. 60.69 Million USD -54.997%
BioNexus Gene Lab Corp. 133.39 Thousand USD -70419.135%
Precipio, Inc. 1.11 Million USD -8329.122%
iSpecimen Inc. 196.24 Thousand USD -47834.714%
Natera, Inc. 441.99 Million USD 78.717%
Aspira Women's Health Inc. 2.26 Million USD -4051.324%
Standard BioTools Inc. 98.21 Million USD 4.216%
23andMe Holding Co. 76.51 Million USD -22.942%
Castle Biosciences, Inc. 15.31 Million USD -514.428%
Personalis, Inc. 48.96 Million USD -92.127%
Aclaris Therapeutics, Inc. 426 Thousand USD -21981.925%
Applied DNA Sciences, Inc. 1.23 Million USD -7499.939%
OpGen, Inc. 13.04 Million USD -621.183%
T2 Biosystems, Inc. 49.49 Million USD -90.046%
Myriad Genetics, Inc. 145 Million USD 35.125%
ICON Public Limited Company 3.93 Billion USD 97.611%
NeoGenomics, Inc. 611.67 Million USD 84.621%
Star Equity Holdings, Inc. 3.6 Million USD -2506.511%
IDEXX Laboratories, Inc. 947.88 Million USD 90.076%
RadNet, Inc. 1.49 Billion USD 93.691%
MDxHealth SA 41.26 Million USD -127.963%
Psychemedics Corporation 2.29 Million USD -3993.516%
Illumina, Inc. 2.26 Billion USD 95.841%
Check-Cap Ltd. - USD -Infinity%
DarioHealth Corp. 29.54 Million USD -218.435%
Fulgent Genetics, Inc. 14.9 Million USD -531.039%
Sera Prognostics, Inc. 1.85 Million USD -4962.917%
ENDRA Life Sciences Inc. 394.4 Thousand USD -23750.985%
OPKO Health, Inc. 326.56 Million USD 71.194%
Medpace Holdings, Inc. 142.12 Million USD 33.811%
Neogen Corporation 906.23 Million USD 89.62%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -10694.662%
Prenetics Global Limited 2.36 Million USD -3870.181%
Mainz Biomed B.V. 7.42 Million USD -1167.643%
bioAffinity Technologies, Inc. 1.57 Million USD -5858.867%
Trinity Biotech plc 67.42 Million USD -39.512%
Neuronetics, Inc. 62.47 Million USD -50.573%
Sotera Health Company 2.32 Billion USD 95.958%
bioAffinity Technologies, Inc. 1.57 Million USD -5858.867%